LogseqFMS/pages/STOP2030___Annual Meeting___2024___Notas.md

• CM:
• Ale: brief intro to all the teams. Listen about the purpose of our presence is. How many goals have already been achieved.
• Help improving the delivery of tools of tools and strategies for controlling STH but also integration with other diseases.
• Charles Mwandawiro: WHO Roadmap 2030. Why 2030? Efforts to control STH. We talk about elimination in 2030. It used to look quite far, but its only 6 years away. STH are ntds.
• NTD Kenya: We're at the boundary. We have a problem of NTDs. It can not be understated. Our colleages from the School of Health launched interventions to combat schisto and STH in 2012. As Dr. Mwandawiro indicated, nosequé. We're still seeing peaks of infection. Albendazole and mebendazole. We're not using a combination. We realized that we're not able to achieve our goal through MDA alone. In the Breaking Transmission Strategy(BTS) also calls for complimentary interventions. How we can augment the existing strategies that we have. The monotherapy might not be effective in the mixed infections we see. After all this years of MDA the remain of the burden might be related to the monotherapy. It reminds me of what we had with LF some years ago. What stop is bringing was implemented in 2018 and 2019. We didn't have a fdc so we had to administer alb and d and ivm. A total of 9 tablets to one individual. In a MDA taht is a challenge: acceptability. I'm happy that through this consortium we're able to reduce maybe the pill count that we'll be administering to the affected members in our community that have this parasitic infection. In line not only with the global roadmap but also with the strategy of the Ministry. The innovation might probably be used it may go a long way to controlling other parasitic infections.
• Charles Mwandawiro: Not only to sort out the problem of sth. The challenge will be: how do we monitor the effects on these other parasites. As we sort the problem of STH some of the biggest beneficiaries will be SAC. Once it comes into use are going to be SAC. The health of the children is going to improve, the general wellbeing too. We invite alguien de School Health en el MoH
• MoH School Health Doctor Stephen Kaliti: I delivered a cohort of very good kids in multiple counties. I got another colleague. I'm a public health specialist. Im passionate on the youth. When I came back they told me, you delivered them, but they are now in school. We live in an age of evidence. The survival of humanity depends on our innovations. RCT gives good evidence, and we like that. Kenia has been burdened with STH. What can we do to fast-track. 30% of our population son SAC. They are a vulnerable population but the burden of this NTDs they haver disporportionate effects on this population. We want to have kenyans that perform at their bests. Distill the evidence and raise it higher. If its doing good in medicine, please do it. very passionate about translating research and evidence into policy. You can cook a good meal but if you don't have anyone to consume you didn't do a good job.
• School Health: Ministry of Education. I'm a teacher of English in the Kenyan School System. I rose from teacher to Teacher Manager. Having managed different schools at diferent levels: from subcounty (districts before), to county (200-300 secondary schools) and national. Children who are healthy will give the best output, that is my interest. We've been doing annual deworming and we have clustered our counties and annually administered drugs. The teachers are trained to give. The children are treated and fed so they are in the best condition, learning and their outcomes are optimal. We take sciences very seriously and STEM is a key foundation. Mwandawiro is a product of our education system.
• Mwandawiro: In the room we have colleagues from Ghana. People from different countries but in Africa we have Ghana and Kenya. We started the journey of STOP in 2018. We had colleages from Ethiopia and Mozambique. Ghana give me some nostalgic memories because in 2002, 2003 we started deworming activities with JICA. They came and stablished ESASIPAC. In Ghana they established WASASIPAC (for the West). We in Kenya and our colleagues in Ghana we're visiting each other and comparing notes. And we're here again in a consortium that joins us together. Please that the team from Ghana includes a prominent researcher, Abraham Oduro.
• Abraham Oduro: Director of Research for GHS. WP2. Dr Opare is the program manager for NTDs. We implement all the policies of the ministry. When I speak I do it for the director general. Division for R&D. We have the needed support to succeed. I wish everybody well and we're here to contribute positively.
• Joseph Opare: we're privileged to be part of this consortium. We continue to have this infection. We've treated this condition for more than 15 years. Multifaceted approach. Happy to be part of this consortium.
• Doris Njomo: